You have read all your free articles, to continue reading subscribe to read the rest of this content.
Immunovia has strengthened its patent protection for pancreatic cancer biomarkers by obtaining a global license from the South Korean company JW BioScience’s IP portfolio. The license agreement gives Immunovia global commercial rights for two biomarkers for early detection of pancreatic cancer.Already a subscriber Login You have read all your free…
The 2015 Nobel Prize in Chemistry honored discoveries about DNA repair that have given us fundamental knowledge of how a living cell functions and are, for instance, used for the development of new cancer treatments. Linus Plym Forshell, PhD, MSc, at the Swedish Patent and Registration Office, proviAlready a subscriber…
The company’s diabetes project is progressing as planned and the company has submitted an enhanced patent application for its novel peptide drug candidate class. A large amount of results have been processed to complete the application submitted in early May 2017. The results show that the neAlready a subscriber Login…
Follicum announced on September 17, 2019 that the company had received a Notice of Allowance from the US Patent and Trademark Office regarding the patent application “Novel Compositions and Uses Thereof”. The patent has now formally been granted by the USPTO. The patent is valid until 2032. Already a subscriber…
